These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 23775597)

  • 1. B cell lymphoma and myeloma in murine Gaucher's disease.
    Pavlova EV; Wang SZ; Archer J; Dekker N; Aerts JM; Karlsson S; Cox TM
    J Pathol; 2013 Sep; 231(1):88-97. PubMed ID: 23775597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of UDP-glucosylceramide synthase in mice prevents Gaucher disease-associated B-cell malignancy.
    Pavlova EV; Archer J; Wang S; Dekker N; Aerts JM; Karlsson S; Cox TM
    J Pathol; 2015 Jan; 235(1):113-24. PubMed ID: 25256118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clonal Immunoglobulin against Lysolipids in the Origin of Myeloma.
    Nair S; Branagan AR; Liu J; Boddupalli CS; Mistry PK; Dhodapkar MV
    N Engl J Med; 2016 Feb; 374(6):555-61. PubMed ID: 26863356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of p38 Mitogen-Activated Protein Kinase in Gaucher's Disease.
    Kitatani K; Wada M; Perry D; Usui T; Sun Y; Obeid LM; Yaegashi N; Grabowski GA; Hannun YA
    PLoS One; 2015; 10(8):e0136633. PubMed ID: 26312487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of brain inflammation to neuronal cell death in neuronopathic forms of Gaucher's disease.
    Vitner EB; Farfel-Becker T; Eilam R; Biton I; Futerman AH
    Brain; 2012 Jun; 135(Pt 6):1724-35. PubMed ID: 22566609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple myeloma arising from monoclonal gammopathy of undetermined significance in a patient with Gaucher's disease.
    Brady K; Corash L; Bhargava V
    Arch Pathol Lab Med; 1997 Oct; 121(10):1108-11. PubMed ID: 9341594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Animal model of Gaucher's disease from targeted disruption of the mouse glucocerebrosidase gene.
    Tybulewicz VL; Tremblay ML; LaMarca ME; Willemsen R; Stubblefield BK; Winfield S; Zablocka B; Sidransky E; Martin BM; Huang SP
    Nature; 1992 Jun; 357(6377):407-10. PubMed ID: 1594045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma Glucosylsphingosine in GBA1 Mutation Carriers with and without Parkinson's Disease.
    Surface M; Balwani M; Waters C; Haimovich A; Gan-Or Z; Marder KS; Hsieh T; Song L; Padmanabhan S; Hsieh F; Merchant KM; Alcalay RN
    Mov Disord; 2022 Feb; 37(2):416-421. PubMed ID: 34741486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complex IgA gammopathy in Gaucher's disease.
    Shvidel L; Hurwitz N; Shtalrid M; Zur S; Oliver O; Berrebi A
    Leuk Lymphoma; 1995 Dec; 20(1-2):165-8. PubMed ID: 8750640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Case report: serendipitous Gaucher's disease presenting as elevated erythrocyte sedimentation rate due to monoclonal gammopathy.
    Liel Y; Hausmann MJ; Mozes M
    Am J Med Sci; 1991 Jun; 301(6):393-4. PubMed ID: 2039025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoglobulin Abnormalities in Gaucher Disease: an Analysis of 278 Patients Included in the French Gaucher Disease Registry.
    Nguyen Y; Stirnemann J; Lautredoux F; Cador B; Bengherbia M; Yousfi K; Hamroun D; Astudillo L; Billette de Villemeur T; Brassier A; Camou F; Dalbies F; Dobbelaere D; Gaches F; Leguy-Seguin V; Masseau A; Pers YM; Pichard S; Serratrice C; Berger MG; Fantin B; Belmatoug N; On Behalf Of The French Evaluation Of Gaucher Disease Treatment Committee
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32069933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gaucher's disease and cancer: a sphingolipid perspective.
    Barth BM; Shanmugavelandy SS; Tacelosky DM; Kester M; Morad SA; Cabot MC
    Crit Rev Oncog; 2013; 18(3):221-34. PubMed ID: 23510065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ablation of the pro-inflammatory master regulator miR-155 does not mitigate neuroinflammation or neurodegeneration in a vertebrate model of Gaucher's disease.
    Watson L; Keatinge M; Gegg M; Bai Q; Sandulescu MC; Vardi A; Futerman AH; Schapira AHV; Burton EA; Bandmann O
    Neurobiol Dis; 2019 Jul; 127():563-569. PubMed ID: 30981829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuronal accumulation of glucosylceramide in a mouse model of neuronopathic Gaucher disease leads to neurodegeneration.
    Farfel-Becker T; Vitner EB; Kelly SL; Bame JR; Duan J; Shinder V; Merrill AH; Dobrenis K; Futerman AH
    Hum Mol Genet; 2014 Feb; 23(4):843-54. PubMed ID: 24064337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunophenotypical comparison of Gaucher's and pseudo-Gaucher cells.
    Florena AM; Franco V; Campesi G
    Pathol Int; 1996 Feb; 46(2):155-60. PubMed ID: 10846564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous detection of Gaucher's disease and renal involvement of non-Hodgkin's lymphoma: the first Asian case report and a review of literature.
    Kim MJ; Suh JT; Lee HJ; Lee WI; Moon A; Lee J; Kang SH; Cho EH; Oh SH; Baek SK; Kim SY; Park TS
    Ann Clin Lab Sci; 2012; 42(3):293-301. PubMed ID: 22964618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Brazilian Rare-Disease Center's Experience with Glucosylsphingosine (lyso-Gb1) in Patients with Gaucher Disease: Exploring a Novel Correlation with IgG Levels in Plasma and a Biomarker Measurement in CSF.
    Vernet Machado Bressan Wilke M; Iop GD; Faqueti L; Lemos da Silva LA; Kubaski F; Poswar FO; Michelin-Tirelli K; Randon D; Borelli WV; Giugliani R; Schwartz IVD
    Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucosylceramide and glucosylsphingosine metabolism in cultured fibroblasts deficient in acid beta-glucosidase activity.
    Sasagasako N; Kobayashi T; Yamaguchi Y; Shinnoh N; Goto I
    J Biochem; 1994 Jan; 115(1):113-9. PubMed ID: 8188616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gaucher's disease and chronic lymphocytic leukemia. Possible pathogenetic link between Gaucher's disease and B-cell proliferations?
    Fox H; McCarthy P; André-Schwartz J; Shoenfeld Y; Miller KB
    Cancer; 1984 Jul; 54(2):312-4. PubMed ID: 6609761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuronopathic Gaucher disease in the mouse: viable combined selective saposin C deficiency and mutant glucocerebrosidase (V394L) mice with glucosylsphingosine and glucosylceramide accumulation and progressive neurological deficits.
    Sun Y; Liou B; Ran H; Skelton MR; Williams MT; Vorhees CV; Kitatani K; Hannun YA; Witte DP; Xu YH; Grabowski GA
    Hum Mol Genet; 2010 Mar; 19(6):1088-97. PubMed ID: 20047948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.